A detailed history of Benjamin F. Edwards & Company, Inc. transactions in Twist Bioscience Corp stock. As of the latest transaction made, Benjamin F. Edwards & Company, Inc. holds 17,166 shares of TWST stock, worth $832,722. This represents 0.01% of its overall portfolio holdings.

Number of Shares
17,166
Previous 308 5473.38%
Holding current value
$832,722
Previous $11,000 7590.91%
% of portfolio
0.01%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$27.95 - $53.0 $471,181 - $893,474
16,858 Added 5473.38%
17,166 $846,000
Q1 2024

Apr 29, 2024

BUY
$32.28 - $41.5 $9,942 - $12,782
308 New
308 $11,000

Others Institutions Holding TWST

About Twist Bioscience Corp


  • Ticker TWST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 56,363,500
  • Market Cap $2.73B
  • Description
  • Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...
More about TWST
Track This Portfolio

Track Benjamin F. Edwards & Company, Inc. Portfolio

Follow Benjamin F. Edwards & Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin F. Edwards & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Benjamin F. Edwards & Company, Inc. with notifications on news.